Showing results (611-620 of 5,638) with videos related to

Sort By:
Pageof 564
BMC Gastroenterology|April 24, 2025
Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistanceJinfeng Wang, Jianfei Shi, Lili Mi, et al.
BMC Gastroenterology|May 1, 2025
Modified triglyceride-glucose indices as novel predictors of metabolic dysfunction-associated fatty liver disease in US adolescents: a nationally representative study from NHANES 2017-2020Yigui Zou, Yu Dai, Ziyuan Li, et al.
BMC Gastroenterology|May 1, 2025
The role of C-reactive protein to lymphocyte ratio in NAFLD and mortality among NAFLD patientsJianxin Xi, Shengnan Wang, Jie Chen, et al.
BMC Gastroenterology|April 18, 2025
Effect of biliopancreatic tree anatomy on development of acute gallstone pancreatitisAhmet Sukru Alparslan, Serkan Ocal, Osman Cagin Buldukoglu, et al.
BMC Gastroenterology|March 29, 2025
Lipopolysaccharide-binding protein (LBP): a prognostic biomarker for gastric cancer linked to immune infiltrationHao Lv, Mei Lv, Xuyang Guo, et al.
BMC Gastroenterology|April 1, 2025
CDH1 genetic variants and its aberrant expression are the risk factors for colorectal cancer metastasisYunbo Wu, Ying Yu, Danyan Li, et al.
BMC Gastroenterology|March 25, 2025
Optimizing outcomes in acute pancreatitis: the impact of of heparin therapy duration on mortality in a multi-center retrospective studyLinlin Fu, Hanyang Li, Qian Ni, et al.
BMC Gastroenterology|November 19, 2025
Association between the red cell distribution Width - coefficient of variation with colon cancer and all-cause mortality: insights from the 1999-2018 NHANESXue Li, Yunxian He, Peiwen Yuan, et al.
BMC Gastroenterology|November 19, 2025
Association between Helicobacter pylori infection and hospital-acquired upper gastrointestinal bleeding: a prospective case-control studySetthachai Piwchan, Ekawee Sripariwuth, Suppana Chuensakul
BMC Gastroenterology|November 19, 2025
Efficacy and safety analysis of D-TACE combined with lenvatinib in the treatment of hepatocellular carcinoma refractory to C-TACEHaohao Lu, Bin Liang, Chuansheng Zheng, et al.
Pageof 564